Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AMNEAL PHARMS

  • FDA Approval
  • Feb. 27, 2024, 09:40 UTC
  • 52
  • 0 comments

FDA approve IRBESARTAN

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Feb. 27, 2024, 09:40 UTC
  • 48
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Feb. 27, 2024, 09:40 UTC
  • 43
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

ALVOTECH USA INC

  • FDA Approval
  • Feb. 26, 2024, 17:03 UTC
  • 56
  • 0 comments

FDA approve ADALIMUMAB-RYVK

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Feb. 26, 2024, 09:59 UTC
  • 46
  • 0 comments

FDA approve ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Comment Full text

AJANTA PHARMA LTD

  • FDA Approval
  • Feb. 26, 2024, 09:59 UTC
  • 52
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

GILEAD SCIENCES INC

  • FDA Approval
  • Feb. 26, 2024, 09:59 UTC
  • 57
  • 0 comments

FDA approve BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

Comment Full text

GLENMARK GENERICS

  • FDA Approval
  • Feb. 26, 2024, 09:59 UTC
  • 48
  • 0 comments

FDA approve TOPIRAMATE

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • Feb. 26, 2024, 09:59 UTC
  • 48
  • 0 comments

FDA approve VEDOLIZUMAB

Comment Full text

ASTRAZENECA AB

  • FDA Approval
  • Feb. 26, 2024, 09:59 UTC
  • 48
  • 0 comments

FDA approve NIRSEVIMAB-ALIP

Comment Full text
  • Previous
  • 541
  • 542
  • 543
  • 544
  • 545
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328517)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183573)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin